Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction

European Journal of Neuroscience

Volumn 25, Issue 6, 2007, Pages 1619-1630

  Newman, Zachary ^a   Malik, Priya ^a   Wu, Tse Yu ^a   Ochoa, Christopher ^a   Watsa, Nayantara ^a   Lindgren, Clark ^a  

^a GRINNELL COLLEGE   (United States)

Author keywords

Anolis carolinensis; Endocannabinoids; Muscarinic; Neuromuscular junction; Synaptic depression

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; ARACHIDONYLCYCLOPROPYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOCANNABINOID; LIPOPROTEIN LIPASE; MUSCARINE; MUSCARINIC RECEPTOR; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; NITRIC OXIDE; PHOSPHOLIPASE C; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SYNTHESIS; LIZARD; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; VERTEBRATE;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM; DRUG INTERACTIONS; ENDOCANNABINOIDS; ENZYME INHIBITORS; INHIBITORY POSTSYNAPTIC POTENTIALS; LIZARDS; MODELS, BIOLOGICAL; MORPHOLINES; MUSCARINE; MUSCARINIC AGONISTS; NEUROMUSCULAR JUNCTION; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1;

EID: 34047276467     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05422.x     Document Type: Article

References (61)

1. Ameri, A. (1999) The effects of cannabinoids on the brain. Prog. Neurobiol., 58, 315-348.
2. Ashton, C.H. (1999) Adverse effects of cannabis and cannabinoids. Br. J. Anaesth., 83, 637-649.
3. Azad, S.C., Marsicano, G., Eberlein, I., Putzke, J., Zieglgansberger, W., Spanagel, R. & Lutz, B. (2001) Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse. Eur. J. Neurosci., 13, 561-568.
4. Beltramo, M., Stella, N., Calignano, A., Lin, S.Y., Makriyannis, A. & Piomelli, D. (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277, 1094-1097.
5. Boehm, S. & Huck, S. (1997) Receptors controlling transmitter release from sympathetic neurons in vitro. Prog. Neurobiol., 51, 225-242.
6. Brenowitz, S.D. & Regehr, W.G. (2003) Calcium dependence of retrograde inhibition by endocannabinoids at synapses onto Purkinje cells. J. Neurosci., 23, 6373-6384.
7. Brown, S.P., Safo, P.K. & Regehr, W.G. (2004) Endocannabinoids inhibit transmission at granule cell to Purkinje cell synapses by modulating three types of presynaptic calcium channels. J. Neurosci., 24, 5623-5631.
8. Caulfield, M.P. (1993) Muscarinic receptors - characterization, coupling and function. Pharmacol. Ther., 58, 319-379.
9. Compton, D.R., Aceto, M.D., Lowe, J. & Martin, B.R. (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther., 277, 586-594.
10. + influx at parallel fibre synapses of the rat cerebellum. J. Physiol., 557, 159-174.
11. Del Castillo, J. & Katz, B. (1954) Quantal components of the end-plate potential. J. Physiol., 124, 560-573.
12. De Petrocellis, L., Bisogno, T., Davis, J.B., Pertwee, R.G. & DiMarzo, V. (2000) Overlap between the ligand recognition properties of the anandamide transport and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett., 483, 52-56.
13. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
14. Diana, M.A., Levenes, C., Mackie, K. & Marty, A. (2002) Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. J. Neurosci., 22, 200-208.
15. Duncan, C.J. & Publicover, S.J. (1979) Inhibitory effects of cholinergic agents on the release of transmitter at the frog neuromuscular junction. J. Physiol., 294, 91-103.
16. Etherington, S.J. & Everett, A.W. (2004) Postsynaptic production of nitric oxide implicated in long-term depression at the mature amphibian (Bufo marinus) neuromuscular junction. J. Physiol., 559, 507-517.
17. 2+-dependent release from rat brain of cannabinoid receptor binding activity. J. Neurochem., 58, 780-782.
18. Freund, T.F., Katona, I. & Piomelli, D. (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev., 83, 1017-1066.
19. 3- mediated indirect suppression through endocannabinoid signaling. Eur. J. Neurosci., 19, 2682-2692.
20. Ganguly, D.K. & Das, M. (1979) Effects of oxotremorine demonstrate presynaptic muscarinic and dopaminergic receptors on motor nerve terminals. Nature, 278, 645-646.
21. Gerdeman, G. & Lovinger, D.M. (2001) CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol., 85, 468-471.
22. Graves, A.R., Lewin, K.A. & Lindgren, C.A. (2004) Nitric oxide, cAMP and the biphasic muscarinic modulation of ACh release at the lizard neuromuscular junction. J. Physiol., 559, 423-432.
23. Hillard, C.J., Edgemond, W.S., Jarrahian, A. & Campbell, W.B. (1997) Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem., 69, 631-638.
24. Howlett, A.C., Barth, F., Bonner, T.I., Cabral, G., Casellas, P., Devane, W.A., Felder, C.C., Herkenham, M., Mackie, K., Martin, B.R., Mechoulam, R. & Pertwee, R.G. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202.
25. Kim, J., Isokawa, M., Ledent, C. & Alger, B.E. (2002) Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J. Neurosci., 22, 10 182-10 191.
26. Kreitzer, A.C. & Regehr, W.G. (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron, 29, 717-727.
27. Kreitzer, A.C. & Regehr, W.G. (2002) Retrograde signaling by endocannabinoids. Curr. Opin. Neurobiol., 12, 324-330.
28. 2+ currents by endocannabinoids released via postsynaptic mGluR activation at a Calyx Synapse. J. Neurosci., 24, 5955-5965.
29. Lindgren, C.A. & Moore, J.W. (1989) Identification of ionic currents at presynaptic nerve endings of the lizard. J. Physiol., 414, 201-222.
30. Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A. & Kano, M. (2001) Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron, 31, 463-475.
31. Martin, B.R., Mechoulam, R. & Razdan, R.K. (1999) Discovery and characterization of endogenous cannabinoids. Life Sci., 65, 573-595.
32. Michaelson, D.M., Avissar, S., Kloog, Y. & Sokolovsky, M. (1979) Mechanism of acetylcholine release: possible involvement of presynaptic muscarinic receptors in regulation of acetylcholine release and protein phosphorylation. Proc. Natl Acad. Sci. U.S.A., 76, 6336-6340.
33. Minic, J., Molgó, J., Karlsson, E. & Krejci, E. (2002) Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase. Eur. J. Neurosci., 15, 439-448.
34. Namiki, S., Kakizawa, S., Hirose, K. & Iino, M. (2005) NO signaling decodes frequency of neuronal activity and generates synapse-specific plasticity in mouse cerebellum. J. Physiol., 566, 849-863.
35. Ohno-Shosaku, T., Maejima, T. & Kano, M. (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron, 29, 729-738.
36. 3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signaling in the hippocampus. Eur. J. Neurosci., 18, 109-116.
37. Pinard, A., Levesque, S., Vallee, J. & Robitaille, R. (2003) Glutamatergic modulation of synaptic plasticity at a PHS vertebrate cholinergic synapse. Eur. J. Neurosci., 18, 3241-3250.
38. Randall, M.D. & Kendall, D.A. (1998) Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol. Sci., 19, 55-58.
39. Robbe, D., Alonso, G., Duchamp, F., Bockaert, J. & Manzoni, O.J. (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic syanapses of the mouse nucleus accumbens. J. Neurosci., 21, 109-116.
40. Romero, J., Garcia-Palomero, D., Lin, S.Y., Ramos, J.A., Makriyannis, A. & Fernandez-Ruiz, J.J. (1996) Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand. Life Sci., 58, 1249-1257.
41. Ronesi, J., Gerdeman, G.L. & Lovinger, D.M. (2004) Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J. Neurosci., 24, 1673-1679.
42. + M-current in hippocampal CA1 neurons. J. Neurosci., 20, 51-58.
43. Slutsky, I., Parnas, H. & Parnas, I. (1999) Presynaptic effects of muscarine on ACh release at the frog neuromuscular junction. J. Physiol., 514, 769-782.
44. 2 muscarinic receptors are involved in controlling the kinetics of ACh release at the frog neuromuscular junction. J. Physiol., 536, 717-725.
45. Spafford, J.D. & Zamponi, G.W. (2003) Functional interactions between presynaptic calcium channels and the neurotransmitter release machinery. Curr. Opin. Neurobiol., 13, 1-7.
46. Standaert, F.G. (1982) Release of transmitter at the neuromuscular junction. Br. J. Anaesth., 54, 131-145.
47. Starke, K., Gothert, M. & Kilbinger, H. (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev., 69, 864-989.
48. Stella, N., Schweitzer, P. & Piomelli, D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature, 388, 773-778.
49. Sullivan, J.M. (1999) Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J. Neurophysiol., 82, 1286-1294.
50. Takahashi, K.A. & Linden, D.J. (2000) Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. J. Neurophysiol., 83, 1167-1180.
51. Thomas, S. & Robitaille, R. (2001) Differential frequency-dependent regulation of transmitter release by endogenous nitric oxide at the amphibian neuromuscular synapse. J. Neurosci., 21, 1087-1095.
52. Turkanis, S.A. & Karler, R. (1986) Effects of delta-9- tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidol on neuromuscular transmission in the frog. Neuropharmacology, 25, 1273-1278.
53. Twitchell, W., Brown, S. & Mackie, K. (1997) Cannabinoids Inhibit N- and P/Q-type Calcium Channels in cultured Rat Hippocampal neurons. J. Neurophysiol, 78, 43-50.
54. Van der Kloot, W. (1994) Anandamide, a naturally-occurring agonist of the cannabinoid receptor, blocks adenylate cyclase at the frog neuromuscular junction. Brain Res., 649, 181-184.
55. 2 receptors. Science, 310, 329-332.
56. Vaughan, C.W., Connor, M., Bagley, E.E. & Christie, M.J. (2000) Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol. Pharmacol., 57, 288-295.
57. Waksman, Y., Olson, J.M., Carliscl, S.J. & Cabral, G.A. (1999) The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J. Pharm. Exp. Ther., 288, 1357-1366.
58. Wali, F.A., Suer, A.H., McAteer, E., Dark, C.H. & Jones, C.J. (1988) Effects of atropine and glycopyrrolate on neuromuscular transmission in the rat phrenic nerve-diaphragm preparation. Gen. Pharmacol., 19, 285-290.
59. Wilson, R.I. & Nicoll, R.A. (2001) Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature, 410, 588-592.
60. Wilson, R.I. & Nicoll, R.A. (2002) Endocannabinoid signaling in the brain. Science, 296, 678-682.
61. Yoshida, T., Hashimoto, K., Zimmer, A., Maejima, T., Araishi, K. & Kano, M. (2002) The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J. Neurosci., 22, 1690-1697.